Leonhard Müllauer

9.8k total citations
198 papers, 5.3k citations indexed

About

Leonhard Müllauer is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Leonhard Müllauer has authored 198 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 56 papers in Molecular Biology and 51 papers in Pathology and Forensic Medicine. Recurrent topics in Leonhard Müllauer's work include Lymphoma Diagnosis and Treatment (34 papers), Cancer Genomics and Diagnostics (29 papers) and Mast cells and histamine (25 papers). Leonhard Müllauer is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Cancer Genomics and Diagnostics (29 papers) and Mast cells and histamine (25 papers). Leonhard Müllauer collaborates with scholars based in Austria, Germany and United States. Leonhard Müllauer's co-authors include Markus Raderer, Peter Valent, Andreas Chott, Berthold Streubel, Wolfgang R. Sperr, Ingrid Simonitsch‐Klupp, Felicitas Oberndorfer, Julius Lukas, Marlene Troch and Bettina Grasl‐Kraupp and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Leonhard Müllauer

190 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonhard Müllauer Austria 39 1.8k 1.3k 1.3k 1.2k 1.0k 198 5.3k
Kiyohiko Hatake Japan 41 1.3k 0.7× 2.3k 1.7× 1.1k 0.8× 1.2k 1.0× 741 0.7× 237 5.1k
Lubomir Sokol United States 37 1.3k 0.7× 1.8k 1.4× 2.0k 1.6× 1.4k 1.2× 1.4k 1.4× 269 5.3k
Antonio Pinto Italy 40 1.3k 0.7× 2.2k 1.7× 2.3k 1.8× 1.6k 1.4× 1.1k 1.1× 239 5.6k
Dina Ben‐Yehuda Israel 35 2.1k 1.1× 1.3k 1.0× 1.4k 1.1× 579 0.5× 1.2k 1.1× 124 4.8k
Dieter K. Hossfeld Germany 36 2.6k 1.4× 1.8k 1.4× 1.2k 0.9× 808 0.7× 1.4k 1.4× 165 6.1k
Cyrus V. Hedvat United States 35 2.6k 1.5× 1.7k 1.3× 530 0.4× 861 0.7× 1.1k 1.1× 76 5.4k
Yasuhiro Oki United States 40 2.2k 1.2× 2.3k 1.8× 3.1k 2.5× 1.0k 0.9× 1.7k 1.7× 207 6.3k
Jane Houldsworth United States 41 2.5k 1.4× 1.2k 0.9× 1.1k 0.9× 596 0.5× 707 0.7× 111 5.1k
Valter Gattei Italy 43 1.7k 0.9× 1.4k 1.1× 2.4k 1.9× 2.1k 1.8× 2.5k 2.5× 222 5.7k
Nikolas von Bubnoff Germany 31 1.1k 0.6× 1.1k 0.9× 481 0.4× 708 0.6× 1.3k 1.3× 138 4.1k

Countries citing papers authored by Leonhard Müllauer

Since Specialization
Citations

This map shows the geographic impact of Leonhard Müllauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonhard Müllauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonhard Müllauer more than expected).

Fields of papers citing papers by Leonhard Müllauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonhard Müllauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonhard Müllauer. The network helps show where Leonhard Müllauer may publish in the future.

Co-authorship network of co-authors of Leonhard Müllauer

This figure shows the co-authorship network connecting the top 25 collaborators of Leonhard Müllauer. A scholar is included among the top collaborators of Leonhard Müllauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonhard Müllauer. Leonhard Müllauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlögl, Ernst, et al.. (2025). NTRK1 Gene Fusions Are Frequent in Juvenile Xanthogranuloma. The American Journal of Surgical Pathology. 49(8). 763–769.
2.
Çifçi, Didem, Erwin Tomasich, Maximilian J. Mair, et al.. (2025). Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases. Acta Neuropathologica Communications. 13(1). 34–34. 1 indexed citations
3.
Grimm, Christoph, Christian Brueffer, Núria Seguí, et al.. (2025). ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer. Cancers. 17(5). 786–786.
4.
Brueffer, Christian, Miguel Alcaide, Lucia Oton, et al.. (2023). #898 Tumor-informed CtDNA detection as a marker for postoperative residual disease in epithelial ovarian cancer – results of a feasibility study. A38.2–A39. 1 indexed citations
5.
Slany, Astrid, Christine Pirker, Johanna C. Mader, et al.. (2023). Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. Journal of Experimental & Clinical Cancer Research. 42(1). 27–27. 13 indexed citations
6.
Senfter, Daniel, Julia Furtner, Christine Haberler, et al.. (2023). Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers. 15(9). 2525–2525. 8 indexed citations
7.
Tomasich, Erwin, Ariane Steindl, Rainer Puhr, et al.. (2023). Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. Clinical Cancer Research. 29(16). 3225–3236. 14 indexed citations
8.
Ghanim, Bahil, Dina Baier, Christine Pirker, et al.. (2022). Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib. Cancers. 14(22). 5602–5602. 7 indexed citations
9.
Hofstetter, Gerda, et al.. (2021). Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients. Biomolecules. 11(11). 1700–1700. 4 indexed citations
10.
Bekos, Christine, Christoph Grimm, Stephan Polterauer, et al.. (2021). Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer. Journal of Personalized Medicine. 11(7). 593–593. 10 indexed citations
11.
Taghizadeh, Hossein, Robert M. Mader, Leonhard Müllauer, et al.. (2020). Precision Medicine for the Management of Therapy Refractory Colorectal Cancer. Journal of Personalized Medicine. 10(4). 272–272. 3 indexed citations
12.
Taghizadeh, Hossein, Matthias Unseld, Robert M. Mader, et al.. (2020). Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI. Journal of Personalized Medicine. 10(4). 188–188. 7 indexed citations
13.
Aust, Stefanie, Richard Schwameis, Leonhard Müllauer, et al.. (2020). Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer. Cancers. 12(3). 548–548. 15 indexed citations
14.
Müllauer, Leonhard. (2017). Next generation sequencing: clinical applications in solid tumours. memo - Magazine of European Medical Oncology. 10(4). 244–247. 17 indexed citations
15.
Thallinger, Christiane, Thorsten Füreder, Matthias Preusser, et al.. (2017). Review of cancer treatment with immune checkpoint inhibitors. Wiener klinische Wochenschrift. 130(3-4). 85–91. 100 indexed citations
16.
Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2015). Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients. Clinical Cancer Research. 21(11). 2506–2513. 66 indexed citations
17.
Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2014). Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients. Clinical Cancer Research. 20(11). 2984–2993. 81 indexed citations
18.
Oschlies, Ilske, Birgit Burkhardt, Catherine Chassagne‐Clément, et al.. (2011). Diagnosis and Immunophenotype of 188 Pediatric Lymphoblastic Lymphomas Treated Within a Randomized Prospective Trial. The American Journal of Surgical Pathology. 35(6). 836–844. 31 indexed citations
19.
Stary, Georg, Irene Klein, Frieder Koszik, et al.. (2009). Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood. 114(18). 3854–3863. 89 indexed citations
20.
Heller, Gerwin, Wolfgang M. Schmidt, Barbara Ziegler, et al.. (2008). Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells. Cancer Research. 68(1). 44–54. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by Lubomir Sokol Breakdown of academic impact, for papers by Antonio Pinto Breakdown of academic impact, for papers by Dina Ben‐Yehuda Breakdown of academic impact, for papers by Dieter K. Hossfeld Breakdown of academic impact, for papers by Cyrus V. Hedvat Breakdown of academic impact, for papers by Yasuhiro Oki Breakdown of academic impact, for papers by Jane Houldsworth Breakdown of academic impact, for papers by Valter Gattei Breakdown of academic impact, for papers by Nikolas von Bubnoff
Rankless by CCL
2026